Diligence memo · auto-generated · as of July 2, 2026
Optiscan Biomedical Corp
Optiscan Biomedical Corp looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Optiscan Biomedical Corp operates in Other Health Care, based in HAYWARD.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Optiscan Biomedical Corp has raised $132M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $32M on 2010-04-09.
Most recent recorded round closed around 2019-03-13.
Valuation (modeled)modeled
Provath models Optiscan Biomedical Corp at approximately $443M (range $47M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.18× the median modeled value of Series B Other Health Care companies in 2019–2021 (78 peers) — value vs value, same stage and era. Within the normal band (118% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 18 months.
Last raise 7.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.4× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 97% of Other Health Care peers (5377 compared).
Modeled value ranks above 93% of those peers.
Closest niche peers: KSMS Holdings, LLC, Infab HoldCo, Inc., Aquity Holdings, Inc., MHH Management Holdco, LLC, Earli Inc..
Peoplefiled
15 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.